- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00768898
Defining the Conjunctival Staining Method: Instillation Volume and Time Course to Assess Staining With Lissamine Green
March 19, 2012 updated by: Alcon Research
The purpose of this study is to determine the correct volume of lissamine green to use when assessing conjunctival staining, and to determine the time course needed to evaluate conjunctival staining after lissamine green has been instilled in the eye.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
30
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Fort Worth, Texas, United States, 76134
- Alcon Call Center for Trial Locations
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
community sample
Description
Inclusion Criteria:
- conjunctival staining
Exclusion Criteria:
- ocular pathology
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
2.5 microliters lissamine green
|
vital stain solution
|
|
5.0 microliters lissamine green
|
vital stain solution
|
|
10.0 microliters lissamine green
|
vital stain solution
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Conjunctival Staining at 1 Minute
Time Frame: 1 minute after instillation
|
Lissamine green was instilled in each eye.
Conjunctival staining was assessed by the investigator in the nasal and temporal sections.
The Oxford Scheme was used for each section, with a possible score of 0-5 for each section, where 0=absent and 5=severe.
The nasal and temporal scores were summed, for a possible score of 0-10 for each eye.
Each subject was represented by a single eye, referred to as the "study eye."
The study eye was defined as the eye that attained the highest stain at any measurement time point during the screening visit.
|
1 minute after instillation
|
|
Conjunctival Staining at 2 Minutes
Time Frame: 2 minutes after instillation
|
Lissamine green was instilled in each eye.
Conjunctival staining was assessed by the investigator in the nasal and temporal sections.
The Oxford Scheme was used for each section, with a possible score of 0-5 for each section, where 0=absent and 5=severe.
The nasal and temporal scores were summed, for a possible score of 0-10 for each eye.
Each subject was represented by a single eye, referred to as the "study eye."
The study eye was defined as the eye that attained the highest stain at any measurement time point during the screening visit.
|
2 minutes after instillation
|
|
Conjunctival Staining at 3 Minutes
Time Frame: 3 minutes after instillation
|
Lissamine green was instilled in each eye.
Conjunctival staining was assessed by the investigator in the nasal and temporal sections.
The Oxford Scheme was used for each section, with a possible score of 0-5 for each section, where 0=absent and 5=severe.
The nasal and temporal scores were summed, for a possible score of 0-10 for each eye.
Each subject was represented by a single eye, referred to as the "study eye."
The study eye was defined as the eye that attained the highest stain at any measurement time point during the screening visit.
|
3 minutes after instillation
|
|
Conjunctival Staining at 4 Minutes
Time Frame: 4 minutes after instillation
|
Lissamine green was instilled in each eye.
Conjunctival staining was assessed by the investigator in the nasal and temporal sections.
The Oxford Scheme was used for each section, with a possible score of 0-5 for each section, where 0=absent and 5=severe.
The nasal and temporal scores were summed, for a possible score of 0-10 for each eye.
Each subject was represented by a single eye, referred to as the "study eye."
The study eye was defined as the eye that attained the highest stain at any measurement time point during the screening visit.
|
4 minutes after instillation
|
|
Conjunctival Staining at 5 Minutes
Time Frame: 5 minutes after instillation
|
Lissamine green was instilled in each eye.
Conjunctival staining was assessed by the investigator in the nasal and temporal sections.
The Oxford Scheme was used for each section, with a possible score of 0-5 for each section, where 0=absent and 5=severe.
The nasal and temporal scores were summed, for a possible score of 0-10 for each eye.
Each subject was represented by a single eye, referred to as the "study eye."
The study eye was defined as the eye that attained the highest stain at any measurement time point during the screening visit.
|
5 minutes after instillation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2008
Primary Completion (Actual)
September 1, 2008
Study Registration Dates
First Submitted
October 6, 2008
First Submitted That Met QC Criteria
October 6, 2008
First Posted (Estimate)
October 8, 2008
Study Record Updates
Last Update Posted (Estimate)
April 13, 2012
Last Update Submitted That Met QC Criteria
March 19, 2012
Last Verified
March 1, 2012
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- M-08-01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Conjunctival Staining
-
Alcon ResearchCompletedConjunctival StainingUnited States
-
Abbott Medical OpticsCompletedCorneal StainingUnited States
-
CooperVision, Inc.CompletedCorneal StainingUnited States
-
Alcon ResearchCompleted
-
Colgate PalmoliveCompletedStainingUnited States
-
Innovative MedicalCompletedCorneal StainingUnited States
-
Innovative MedicalCompletedCorneal StainingUnited States
-
dott. Lorenzo BevilacquaCompletedStaining Effect of ChlorhexidineItaly
-
University of PaviaCompletedExtrinsic Staining of Tooth - MedicationItaly
-
National University of MalaysiaNot yet recruitingDry Eye | Dry Eye Syndromes | Contact Lens-induced Corneal Fluorescein StainingMalaysia
Clinical Trials on 2.5/5.0/10.0 µL lissamine green
-
AstraZenecaCompletedDiabetes Mellitus, Non-Insulin-DependentUnited States
-
Eisai Inc.Completed